{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:46:31Z","timestamp":1783334791440,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.modpat.2022.100050","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T15:35:37Z","timestamp":1673537737000},"page":"100050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Novel BCMA Immunohistochemistry Assay Reveals a Heterogenous and Dynamic BCMA Expression Profile in Multiple Myeloma"],"prefix":"10.1016","volume":"36","author":[{"given":"Mingjun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2379-0386","authenticated-orcid":false,"given":"Falon","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wurmser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hytham","family":"Al-Masri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntae","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hersey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2022.100050_bib1","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3389\/fimmu.2018.01821","article-title":"Targeting B cell maturation antigen (BCMA) in multiple myeloma: potential uses of BCMA-based immunotherapy","volume":"9","author":"Cho","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2022.100050_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"O\u2019Connor","year":"2004","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"10.1016\/j.modpat.2022.100050_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood-2003-06-2043","article-title":"Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival","volume":"103","author":"Novak","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2022.100050_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1615\/CritRevImmunol.v32.i4.10","article-title":"Regulatory roles of the tumor necrosis factor receptor BCMA","volume":"32","author":"Coquery","year":"2012","journal-title":"Crit Rev Immunol"},{"issue":"25","key":"10.1016\/j.modpat.2022.100050_bib5","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1182\/blood-2016-01-691162","article-title":"APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment","volume":"127","author":"Tai","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2022.100050_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.192.1.129","article-title":"BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population","volume":"192","author":"Thompson","year":"2000","journal-title":"J\u00a0Exp Med"},{"issue":"7","key":"10.1016\/j.modpat.2022.100050_bib7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/intimm\/7.7.1093","article-title":"BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes","volume":"7","author":"Gras","year":"1995","journal-title":"Int Immunol"},{"issue":"40","key":"10.1016\/j.modpat.2022.100050_bib8","doi-asserted-by":"crossref","first-page":"25764","DOI":"10.18632\/oncotarget.25359","article-title":"Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma","volume":"9","author":"Bu","year":"2018","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.modpat.2022.100050_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3324\/haematol.2016.150896","article-title":"Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients","volume":"102","author":"Ghermezi","year":"2017","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.modpat.2022.100050_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/bjh.14145","article-title":"Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma","volume":"174","author":"Lee","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.modpat.2022.100050_bib11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.165.3.1322","article-title":"TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase","volume":"165","author":"Hatzoglou","year":"2000","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.modpat.2022.100050_bib12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ccell.2017.02.002","article-title":"Target expression, generation, preclinical activity, and pharmacokinetics of the BCMA-T cell bispecific antibody EM801 for multiple myeloma treatment","volume":"31","author":"Seckinger","year":"2017","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.modpat.2022.100050_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2217\/imt.15.77","article-title":"Targeting B-cell maturation antigen in multiple myeloma","volume":"7","author":"Tai","year":"2015","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.modpat.2022.100050_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0968-0004(97)01164-X","article-title":"Modularity in the TNF-receptor family","volume":"23","author":"Naismith","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.modpat.2022.100050_bib15","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1038\/ncomms8333","article-title":"\u03b3-Secretase directly sheds the survival receptor BCMA from plasma cells","volume":"6","author":"Laurent","year":"2015","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.modpat.2022.100050_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2141.2012.09241.x","article-title":"Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival","volume":"158","author":"Sanchez","year":"2012","journal-title":"Br J Haematol"},{"issue":"Pt 2","key":"10.1016\/j.modpat.2022.100050_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brainresbull.2016.04.019","article-title":"Physiological and pathological roles of the \u03b3-secretase complex","volume":"126","author":"Carroll","year":"2016","journal-title":"Brain Res Bull"},{"issue":"11","key":"10.1016\/j.modpat.2022.100050_bib18","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.192.11.1677","article-title":"A\u00a0soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth","volume":"192","author":"Rennert","year":"2000","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.modpat.2022.100050_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin Immunol"},{"issue":"9","key":"10.1016\/j.modpat.2022.100050_bib20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.it.2018.07.002","article-title":"Shedding of BAFF\/APRIL receptors controls B cells","volume":"39","author":"Meinl","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.modpat.2022.100050_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.semcdb.2020.05.019","article-title":"The substrate repertoire of \u03b3-secretase\/presenilin","volume":"105","author":"G\u00fcner","year":"2020","journal-title":"Semin Cell Dev Biol"},{"issue":"19","key":"10.1016\/j.modpat.2022.100050_bib22","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/blood.2019000050","article-title":"\u03b3-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma","volume":"134","author":"Pont","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.modpat.2022.100050_bib24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3390\/cancers12061473","article-title":"BCMA-targeting therapy: driving a new era of immunotherapy in multiple myeloma","volume":"12","author":"Cho","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.modpat.2022.100050_bib25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41375-020-0734-z","article-title":"B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches","volume":"34","author":"Shah","year":"2020","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.modpat.2022.100050_bib26","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/14712598.2019.1641196","article-title":"B\u00a0cell maturation antigen (BCMA)-based immunotherapy for multiple myeloma","volume":"19","author":"Tai","year":"2019","journal-title":"Expert Opin Biol Ther"},{"issue":"15","key":"10.1016\/j.modpat.2022.100050_bib27","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1200\/JCO.2019.37.15_suppl.8012","article-title":"Safety and tolerability of BION-1301 in adults with relapsed or refractory multiple myeloma","volume":"37","author":"Bensinger","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.modpat.2022.100050_bib28","doi-asserted-by":"crossref","first-page":"TPS8054","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS8054","article-title":"SGNBCMA-001: a phase 1 study of SEA-BCMA, a non-fucosylated monoclonal antibody, in subjects with relapsed or refractory multiple myeloma","volume":"37","author":"Abdallah","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.modpat.2022.100050_bib29","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1200\/JCO.2020.38.15_suppl.8502","article-title":"DREAMM-6: safety and tolerability of belantamab mafodotin in combination with bortezomib\/dexamethasone in relapsed\/refractory multiple myeloma (RRMM)","volume":"38","author":"Nooka","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2022.100050_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1470-2045(19)30788-0","article-title":"Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study","volume":"21","author":"Lonial","year":"2020","journal-title":"Lancet Oncol"},{"issue":"20","key":"10.1016\/j.modpat.2022.100050_bib31","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1182\/blood-2013-10-535088","article-title":"Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma","volume":"123","author":"Tai","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2022.100050_bib32","series-title":"Interim results from the first phase 1 clinical study of the B-cell maturation antigen (BCMA) 2+1 T cell engager (TCE) CC-93269 in patients (pts) with relapsed\/refractory multiple myeloma (RRMM)","first-page":"S205","volume":"295025","author":"Costa","year":"2020"},{"key":"10.1016\/j.modpat.2022.100050_bib33","series-title":"A\u00a0phase 1 study of teclistamab, a humanized B-cell maturation antigen (BCMA)\u00a0\u00d7 CD3 bispecific antibody, for the treatment of relapsed and\/or refractory multiple myeloma (RRMM)","author":"Mateos","year":"2020"},{"issue":"18","key":"10.1016\/j.modpat.2022.100050_bib34","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.modpat.2022.100050_bib35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1200\/JCO.19.02657","article-title":"Anti-B-cell maturation antigen BiTE molecule AMG 420 induces responses in multiple myeloma","volume":"38","author":"Topp","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2022.100050_bib36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/hum.2018.001","article-title":"Effective targeting of multiple B-cell maturation antigen-expressing hematological malignances by anti-B-cell maturation antigen chimeric antigen receptor T cells","volume":"29","author":"Friedman","year":"2018","journal-title":"Hum Gene Ther"},{"issue":"8","key":"10.1016\/j.modpat.2022.100050_bib37","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1158\/1078-0432.CCR-12-2422","article-title":"B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma","volume":"19","author":"Carpenter","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.modpat.2022.100050_bib38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood-2006-02-001800","article-title":"Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness","volume":"109","author":"Schwaller","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2022.100050_bib39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/1535-7163.MCT-06-0254","article-title":"The rGel\/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA","volume":"6","author":"Lyu","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10.1016\/j.modpat.2022.100050_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/2643-3230.BCD-20-0122","article-title":"Dual targeting with CAR T cells to limit antigen escape in multiple myeloma","volume":"1","author":"Simon","year":"2020","journal-title":"Blood Cancer Discov"},{"issue":"15","key":"10.1016\/j.modpat.2022.100050_bib41","doi-asserted-by":"crossref","first-page":"8503","DOI":"10.1200\/JCO.2020.38.15_suppl.8503","article-title":"Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-targeted CAR T-cell therapy, in patients with relapsed and refractory multiple myeloma (RRMM): initial KarMMa results","volume":"38","author":"Munshi","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.modpat.2022.100050_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.leukres.2018.07.015","article-title":"Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in myeloma","volume":"71","author":"Salem","year":"2018","journal-title":"Leuk Res"},{"issue":"12","key":"10.1016\/j.modpat.2022.100050_bib43","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/j.1460-9568.2008.06552.x","article-title":"Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry","volume":"28","author":"Fritschy","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.modpat.2022.100050_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/srep00028","article-title":"Non-specific binding of antibodies in immunohistochemistry: fallacies and facts","volume":"1","author":"Buchwalow","year":"2011","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.modpat.2022.100050_bib45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0300985813505879","article-title":"When tissue antigens and antibodies get\u00a0along: revisiting the technical aspects of immunohistochemistry\u2014the red, brown, and blue technique","volume":"51","author":"Ramos-Vara","year":"2014","journal-title":"Vet Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2022.100050_bib46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1515\/bc.2010.086","article-title":"Structure, mechanism and inhibition of gamma-secretase and presenilin-like proteases","volume":"391","author":"Wolfe","year":"2010","journal-title":"Biol Chem"},{"issue":"2","key":"10.1016\/j.modpat.2022.100050_bib47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41388-018-0465-z","article-title":"Gamma-secretase-dependent signaling of receptor tyrosine kinases","volume":"38","author":"Merilahti","year":"2019","journal-title":"Oncogene"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:23:42Z","timestamp":1760232222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222007268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0893395222007268"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2022.100050","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel BCMA Immunohistochemistry Assay Reveals a Heterogenous and Dynamic BCMA Expression Profile in Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2022.100050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100050"}}